• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后营养指数是一种基于炎症与营养的新型鼻咽癌预后因素。

The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma.

作者信息

Jiang Yan-Ming, Huang Shi-Ting, Pan Xin-Bin, Ma Jia-Lin, Zhu Xiao-Dong

机构信息

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.

Department of Oncology, Affiliated Wuming Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Nutr. 2023 Feb 16;10:1036572. doi: 10.3389/fnut.2023.1036572. eCollection 2023.

DOI:10.3389/fnut.2023.1036572
PMID:36875852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977787/
Abstract

PURPOSE

This study explored the relationship between the prognostic nutritional index (PNI) and overall survival rate (OS) in patients with nasopharyngeal carcinoma (NPC), and established and validated an effective nomogram to predict clinical outcomes.

METHODS

This study included 618 patients newly diagnosed with locoregionally advanced NPC. They were divided into training and validation cohorts at a ratio of 2:1 based on random numbers. The primary endpoint of this study was OS, progression-free survival (PFS) was the second endpoint. A nomogram was drawn from the results of multivariate analyses. Harrell's concordance index (C-index), area under the receiver operator characteristic curve (AUC), and decision curve analysis (DCA) were used to evaluate the clinical usefulness and predictive ability of the nomogram and were compared to the current 8th edition of the International Union Against Cancer/American Joint Committee (UICC/AJCC) staging system.

RESULTS

The PNI cutoff value was 48.1. Univariate analysis revealed that age ( < 0.001), T stage ( < 0.001), N stage ( = 0.036), tumor stage ( < 0.001), PNI ( = 0.001), lymphocyte-neutrophil ratio (NLR, = 0.002), and lactate dehydrogenase (LDH, = 0.009) were significantly associated with OS, age ( = 0.001), T-stage ( < 0.001), tumor stage ( < 0.001), N-stage ( = 0.011), PNI ( = 0.003), NLR ( = 0.051), and LDH ( = 0.03) were significantly associated with PFS. Multivariate analysis showed that age ( < 0.001), T-stage ( < 0.001), N-stage( = 0.02), LDH ( = 0.032), and PNI ( = 0.006) were significantly associated with OS, age ( = 0.004), T-stage (<0.001), N-stage (<0.001), PNI ( = 0.022) were significantly associated with PFS. The C-index of the nomogram was 0.702 (95% confidence interval [CI]: 0.653-0.751). The Akaike information criterion (AIC) value of the nomogram for OS was 1142.538. The C-index of the TNM staging system was 0.647 (95% CI, 0.594-0.70) and the AIC was 1163.698. The C-index, DCA, and AUC of the nomogram demonstrated its clinical value and higher overall net benefit compared to the 8th edition of the TNM staging system.

CONCLUSION

The PNI represents a new inflammation-nutrition-based prognostic factor for patients with NPC. In the proposed nomogram, PNI and LDH were present, which led to a more accurate prognostic prediction than the current staging system for patients with NPC.

摘要

目的

本研究探讨鼻咽癌(NPC)患者的预后营养指数(PNI)与总生存率(OS)之间的关系,并建立和验证一种有效的列线图以预测临床结局。

方法

本研究纳入618例新诊断为局部晚期NPC的患者。根据随机数字以2:1的比例将他们分为训练队列和验证队列。本研究的主要终点是OS,无进展生存期(PFS)是次要终点。根据多变量分析结果绘制列线图。使用Harrell一致性指数(C指数)、受试者工作特征曲线下面积(AUC)和决策曲线分析(DCA)来评估列线图的临床实用性和预测能力,并与当前第8版国际抗癌联盟/美国联合委员会(UICC/AJCC)分期系统进行比较。

结果

PNI临界值为48.1。单变量分析显示,年龄(<0.001)、T分期(<0.001)、N分期(=0.036)、肿瘤分期(<0.001)、PNI(=0.001)、淋巴细胞与中性粒细胞比值(NLR,=0.002)和乳酸脱氢酶(LDH,=0.009)与OS显著相关;年龄(=0.001)、T分期(<0.001)、肿瘤分期(<0.001)、N分期(=0.011)、PNI(=0.003)、NLR(=0.051)和LDH(=0.03)与PFS显著相关。多变量分析显示,年龄(<0.001);T分期(<0.001)、N分期(=0.02)、LDH(=0.032)和PNI(=0.006)与OS显著相关;年龄(=0.004)、T分期(<0.001)、N分期(<0.001)、PNI(=0.022)与PFS显著相关。列线图C指数为0.702(95%置信区间[CI]:0.653-0.751)。OS列线图的赤池信息准则(AIC)值为1142.538。TNM分期系统C指数为0.647(95%CI,0.594-0.70),AIC为1163.698。列线图的C指数、DCA和AUC表明其具有临床价值,且与第8版TNM分期系统相比具有更高的总体净效益。

结论

PNI是一种基于炎症-营养的新的NPC患者预后因素。在提出的列线图中纳入了PNI和LDH,与当前分期系统相比,能对NPC患者进行更准确的预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/0370937f69df/fnut-10-1036572-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/0e5fe1e55706/fnut-10-1036572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/e2487eb28f50/fnut-10-1036572-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/dd3d2f17c3b3/fnut-10-1036572-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/3096667c37ab/fnut-10-1036572-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/32c21cb2a8f9/fnut-10-1036572-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/80115a0c4d98/fnut-10-1036572-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/56ed066e4363/fnut-10-1036572-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/e30f06c5c4db/fnut-10-1036572-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/225807d7865c/fnut-10-1036572-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/d818c2ced2ee/fnut-10-1036572-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/0370937f69df/fnut-10-1036572-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/0e5fe1e55706/fnut-10-1036572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/e2487eb28f50/fnut-10-1036572-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/dd3d2f17c3b3/fnut-10-1036572-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/3096667c37ab/fnut-10-1036572-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/32c21cb2a8f9/fnut-10-1036572-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/80115a0c4d98/fnut-10-1036572-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/56ed066e4363/fnut-10-1036572-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/e30f06c5c4db/fnut-10-1036572-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/225807d7865c/fnut-10-1036572-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/d818c2ced2ee/fnut-10-1036572-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/024a/9977787/0370937f69df/fnut-10-1036572-g011.jpg

相似文献

1
The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma.预后营养指数是一种基于炎症与营养的新型鼻咽癌预后因素。
Front Nutr. 2023 Feb 16;10:1036572. doi: 10.3389/fnut.2023.1036572. eCollection 2023.
2
External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.基于第 8 版 AJCC/UICC 分期系统的局部晚期鼻咽癌预后列线图的外部有效性:一项回顾性队列研究。
Cancer Commun (Lond). 2018 Sep 3;38(1):55. doi: 10.1186/s40880-018-0324-x.
3
Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.治疗前预后营养指数和乳酸脱氢酶在局部晚期鼻咽癌患者中的预后价值
Ann Palliat Med. 2021 Apr;10(4):4122-4133. doi: 10.21037/apm-20-2033. Epub 2021 Mar 23.
4
Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.基于炎症生物标志物和营养指标的列线图预测局部晚期鼻咽癌的总生存期
J Inflamm Res. 2022 May 16;15:2971-2981. doi: 10.2147/JIR.S366299. eCollection 2022.
5
Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.纳入血液学标志物和临床特征的鼻咽癌患者预后列线图。
Int J Biol Sci. 2018 Apr 5;14(5):549-556. doi: 10.7150/ijbs.24374. eCollection 2018.
6
[Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].[接受颈清扫术的舌鳞状细胞癌患者生存预后列线图的建立与验证]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Feb 18;56(1):120-130. doi: 10.19723/j.issn.1671-167X.2024.01.019.
7
Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.纳入TNM分期、诱导化疗后肿瘤体积和爱泼斯坦-巴尔病毒DNA载量的局部晚期鼻咽癌患者预后列线图的建立。
Front Oncol. 2021 Jun 16;11:683475. doi: 10.3389/fonc.2021.683475. eCollection 2021.
8
Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.非转移性鼻咽癌治疗列线图模型的建立。
JAMA Netw Open. 2020 Dec 1;3(12):e2029882. doi: 10.1001/jamanetworkopen.2020.29882.
9
Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.用于在调强放射治疗时代优化美国癌症联合委员会/国际抗癌联盟鼻咽癌第8版分期系统预后预测的预后列线图。
Cancer. 2016 Nov 15;122(21):3307-3315. doi: 10.1002/cncr.30198. Epub 2016 Jul 19.
10
Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma.基于乳酸脱氢酶与白蛋白比值(LAR)和血小板与淋巴细胞比值(PLR)的列线图预测鼻咽癌患者的生存率
J Inflamm Res. 2021 Aug 20;14:4019-4033. doi: 10.2147/JIR.S322475. eCollection 2021.

引用本文的文献

1
Predicting pathological response of resectable esophageal squamous cell carcinoma to neoadjuvant anti-PD-1 with chemotherapy using serum inflammation indexes.利用血清炎症指标预测可切除食管鳞状细胞癌对新辅助抗程序性死亡蛋白1联合化疗的病理反应
Sci Rep. 2025 Jul 31;15(1):27914. doi: 10.1038/s41598-025-11590-x.
2
Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.将泛免疫炎症值纳入鼻咽癌个性化生存预测:一项大规模长期回顾性研究
BMC Cancer. 2025 Jul 21;25(1):1194. doi: 10.1186/s12885-025-14413-4.
3
Cholesterol-to-lymphocyte ratio (CLR)-based nomogram as a prognostic tool in nasopharyngeal carcinoma: a large-scale long-term retrospective study.

本文引用的文献

1
Low prognostic nutritional index is associated with poor outcome in middle-aged and elderly patients with non-metastatic nasopharyngeal carcinoma: a retrospective cohort study.低预后营养指数与中老年非转移性鼻咽癌患者不良预后相关:一项回顾性队列研究。
Support Care Cancer. 2022 Nov;30(11):8895-8904. doi: 10.1007/s00520-022-07286-x. Epub 2022 Jul 25.
2
Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.基于炎症生物标志物和营养指标的列线图预测局部晚期鼻咽癌的总生存期
J Inflamm Res. 2022 May 16;15:2971-2981. doi: 10.2147/JIR.S366299. eCollection 2022.
3
基于胆固醇与淋巴细胞比值(CLR)的列线图作为鼻咽癌预后工具的大规模长期回顾性研究
Eur J Med Res. 2025 Jul 21;30(1):644. doi: 10.1186/s40001-025-02793-z.
4
Predictive Effect of Prognostic Nutritional Index on Lymph Node Regression Rate in Patients with Locally Advanced Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.预后营养指数对局部晚期鼻咽癌同步放化疗患者淋巴结消退率的预测作用
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251356541. doi: 10.1177/15330338251356541. Epub 2025 Jul 2.
5
Development of a predictive nomogram based on preoperative inflammation-nutrition-related markers for prognosis in locally advanced lip squamous cell carcinoma after surgical treatment.基于术前炎症-营养相关标志物的预测列线图在局部晚期唇鳞状细胞癌手术治疗后预后评估中的应用
BMC Oral Health. 2025 Feb 20;25(1):268. doi: 10.1186/s12903-025-05663-6.
6
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study.血清炎症标志物在接受手术的食管鳞状细胞癌患者中的预后价值:一项两中心回顾性队列研究
BMC Cancer. 2025 Feb 7;25(1):213. doi: 10.1186/s12885-025-13600-7.
7
Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.用于预测接受同步放化疗的鼻咽癌患者总生存期的、纳入中性粒细胞与白蛋白比值的预后列线图的开发与验证
Heliyon. 2024 Dec 3;11(1):e40881. doi: 10.1016/j.heliyon.2024.e40881. eCollection 2025 Jan 15.
8
Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA.血浆EB病毒DNA阴性的非转移性鼻咽癌中免疫炎症和营养指标的预后价值
Ther Adv Med Oncol. 2024 Oct 14;16:17588359241286489. doi: 10.1177/17588359241286489. eCollection 2024.
9
Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.接受调强放疗的鼻咽癌患者炎症标志物的预后研究
Cancer Manag Res. 2024 Sep 30;16:1321-1328. doi: 10.2147/CMAR.S481142. eCollection 2024.
10
Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.基于随机生存森林建立的甘油三酯-炎症评分预测鼻咽癌患者生存:一项回顾性研究。
Front Immunol. 2024 Apr 26;15:1375931. doi: 10.3389/fimmu.2024.1375931. eCollection 2024.
The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis.
预后营养指数(PNI)对新诊断弥漫性大B细胞淋巴瘤患者的价值:基于倾向评分匹配分析的HHLWG多中心回顾性研究
J Inflamm Res. 2021 Oct 27;14:5513-5522. doi: 10.2147/JIR.S340822. eCollection 2021.
4
Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma.治疗后预后营养指数及其动态变化是无转移性鼻咽癌生存的独立预后因素。
Support Care Cancer. 2022 Mar;30(3):2131-2139. doi: 10.1007/s00520-021-06627-6. Epub 2021 Oct 22.
5
Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma.基于乳酸脱氢酶与白蛋白比值(LAR)和血小板与淋巴细胞比值(PLR)的列线图预测鼻咽癌患者的生存率
J Inflamm Res. 2021 Aug 20;14:4019-4033. doi: 10.2147/JIR.S322475. eCollection 2021.
6
A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma.基于血浆 EBV DNA 用于鼻咽癌的使用:系统综述和推荐意见
Eur J Cancer. 2021 Aug;153:109-122. doi: 10.1016/j.ejca.2021.05.022. Epub 2021 Jun 18.
7
Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.治疗前预后营养指数和乳酸脱氢酶在局部晚期鼻咽癌患者中的预后价值
Ann Palliat Med. 2021 Apr;10(4):4122-4133. doi: 10.21037/apm-20-2033. Epub 2021 Mar 23.
8
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma.乳酸脱氢酶动力学可预测复发性转移性鼻咽癌的化疗反应。
Ther Adv Med Oncol. 2020 Nov 13;12:1758835920970050. doi: 10.1177/1758835920970050. eCollection 2020.
9
Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT).中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及淋巴细胞与单核细胞比值(LMR)变化对接受根治性放化疗(dCRT)的宫颈癌患者的预后价值。
Clin Chim Acta. 2020 Nov;510:711-716. doi: 10.1016/j.cca.2020.09.008. Epub 2020 Sep 11.
10
Lactate modulation of immune responses in inflammatory versus tumour microenvironments.在炎症和肿瘤微环境中,乳酸对免疫反应的调节作用。
Nat Rev Immunol. 2021 Mar;21(3):151-161. doi: 10.1038/s41577-020-0406-2. Epub 2020 Aug 24.